» Articles » PMID: 25205072

A Novel Method for Differentiation of Human Mesenchymal Stem Cells into Smooth Muscle-like Cells on Clinically Deliverable Thermally Induced Phase Separation Microspheres

Overview
Date 2014 Sep 11
PMID 25205072
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Muscle degeneration is a prevalent disease, particularly in aging societies where it has a huge impact on quality of life and incurs colossal health costs. Suitable donor sources of smooth muscle cells are limited and minimally invasive therapeutic approaches are sought that will augment muscle volume by delivering cells to damaged or degenerated areas of muscle. For the first time, we report the use of highly porous microcarriers produced using thermally induced phase separation (TIPS) to expand and differentiate adipose-derived mesenchymal stem cells (AdMSCs) into smooth muscle-like cells in a format that requires minimal manipulation before clinical delivery. AdMSCs readily attached to the surface of TIPS microcarriers and proliferated while maintained in suspension culture for 12 days. Switching the incubation medium to a differentiation medium containing 2 ng/mL transforming growth factor beta-1 resulted in a significant increase in both the mRNA and protein expression of cell contractile apparatus components caldesmon, calponin, and myosin heavy chains, indicative of a smooth muscle cell-like phenotype. Growth of smooth muscle cells on the surface of the microcarriers caused no change to the integrity of the polymer microspheres making them suitable for a cell-delivery vehicle. Our results indicate that TIPS microspheres provide an ideal substrate for the expansion and differentiation of AdMSCs into smooth muscle-like cells as well as a microcarrier delivery vehicle for the attached cells ready for therapeutic applications.

Citing Articles

Injectable biodegradable microcarriers for iPSC expansion and cardiomyocyte differentiation.

Bettini A, Camelliti P, Stuckey D, Day R Adv Sci (Weinh). 2024; 11(32):e2404355.

PMID: 38900068 PMC: 11348074. DOI: 10.1002/advs.202404355.


Bioprocessing Considerations towards the Manufacturing of Therapeutic Skeletal and Smooth Muscle Cells.

Franchi-Mendes T, Silva M, Cartaxo A, Fernandes-Platzgummer A, Cabral J, da Silva C Bioengineering (Basel). 2023; 10(9).

PMID: 37760170 PMC: 10525286. DOI: 10.3390/bioengineering10091067.


A low dose cell therapy system for treating osteoarthritis: study and mechanistic investigations.

Wang B, Liu W, Li J, Chai S, Xing D, Yu H Bioact Mater. 2021; 7:478-490.

PMID: 34466747 PMC: 8379370. DOI: 10.1016/j.bioactmat.2021.05.029.


Fabrication and Characterization of Pectin Hydrogel Nanofiber Scaffolds for Differentiation of Mesenchymal Stem Cells into Vascular Cells.

Li N, Xue F, Zhang H, Sanyour H, Rickel A, Uttecht A ACS Biomater Sci Eng. 2021; 5(12):6511-6519.

PMID: 33417803 PMC: 11268401. DOI: 10.1021/acsbiomaterials.9b01178.


Insulin-Producing Cell Transplantation Platform for Veterinary Practice.

Kuncorojakti S, Srisuwatanasagul S, Kradangnga K, Sawangmake C Front Vet Sci. 2020; 7:4.

PMID: 32118053 PMC: 7028771. DOI: 10.3389/fvets.2020.00004.


References
1.
Allaire E, Muscatelli-Groux B, Guinault A, Pages C, Goussard A, Mandet C . Vascular smooth muscle cell endovascular therapy stabilizes already developed aneurysms in a model of aortic injury elicited by inflammation and proteolysis. Ann Surg. 2004; 239(3):417-27. PMC: 1356242. DOI: 10.1097/01.sla.0000114131.79899.82. View

2.
Tholpady S, Katz A, Ogle R . Mesenchymal stem cells from rat visceral fat exhibit multipotential differentiation in vitro. Anat Rec A Discov Mol Cell Evol Biol. 2003; 272(1):398-402. DOI: 10.1002/ar.a.10039. View

3.
Oughlis S, Lessim S, Changotade S, Poirier F, Bollotte F, Peltzer J . The osteogenic differentiation improvement of human mesenchymal stem cells on titanium grafted with polyNaSS bioactive polymer. J Biomed Mater Res A. 2012; 101(2):582-9. DOI: 10.1002/jbm.a.34336. View

4.
Leeper N, Hunter A, Cooke J . Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells. Circulation. 2010; 122(5):517-26. PMC: 2920605. DOI: 10.1161/CIRCULATIONAHA.109.881441. View

5.
Keshaw H, Georgiou G, Blaker J, Forbes A, Knowles J, Day R . Assessment of polymer/bioactive glass-composite microporous spheres for tissue regeneration applications. Tissue Eng Part A. 2008; 15(7):1451-61. DOI: 10.1089/ten.tea.2008.0203. View